Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
Anaesthesiology Intensive Therapy · 2023
DOI: 10.5114/ait.2023.130640 ↗Kurz gefasst
Leserbrief in der Zeitschrift Anaesthesiology Intensive Therapy, 2023. Verfasst von Stephania Paredes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic, United Sates. Hauptthemen laut MEDLINE: Neuromuscular Blockade, Anesthetics, Neuromuscular Diseases. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
AMA Paredes S, Torres V, Chaves-Cardona H, Porter SB, Renew J. Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”. Anaesthesiology Intensive Therapy. 2023. doi:10.5114/ait.2023.130640. APA Paredes, S., Torres, V., Chaves-Cardona, H., Porter, S. B., & Renew, J. (2023). Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”. Anaesthesiology Intensive Therapy. https://doi.org/10.5114/ait.2023.130640 Chicago Paredes, Stephania, Vivian Hernandez Torres, Harold Chaves-Cardona, Steven B Porter, and Johnathan Ross Renew. 2023. "Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”". Anaesthesiology Intensive Therapy. doi:10.5114/ait.2023.130640. Harvard Paredes, S., Torres, V., Chaves-Cardona, H., Porter, S., and Renew, J. (2023). Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”. Anaesthesiology Intensive Therapy. https://doi.org/10.5114/ait.2023.130640 MLA Paredes, Stephania et al. "Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”." Anaesthesiology Intensive Therapy, 2023. doi:10.5114/ait.2023.130640. Vancouver Paredes S, Torres V, Chaves-Cardona H, Porter S, Renew J. Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”. Anaesthesiology Intensive Therapy. 2023. doi:10.5114/ait.2023.130640.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cleveland Clinic, United Sates.
- Mayo Clinic, United States.
Zitieren
APA
Paredes, S., Torres, V. H., Chaves-Cardona, H., Porter, S., & Renew, J. R. (2023). Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”. Anaesthesiology Intensive Therapy. https://doi.org/10.5114/ait.2023.130640
Vancouver
Paredes S, Torres VH, Chaves-Cardona H, Porter S, Renew JR. Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”. Anaesthesiology Intensive Therapy. 2023. doi:10.5114/ait.2023.130640
BibTeX
@article{Paredes2023,
author = {Paredes, Stephania and Torres, Vivian Hernandez and Chaves-Cardona, Harold and Porter, Steven and Renew, Johnathan Ross},
title = {Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”},
journal = {Anaesthesiology Intensive Therapy},
year = {2023},
doi = {10.5114/ait.2023.130640}
}
EUVIMED